Literature DB >> 12455030

Suppression of lung metastasis of mouse Lewis lung cancer P29 with transfection of the ganglioside GM2/GD2 synthase gene.

Ho-Hsiang Chen1, Satoshi Fukumoto, Keiko Furukawa, Akimasa Nakao, Seiji Akiyama, Takeshi Urano, Koichi Furukawa.   

Abstract

Ganglioside functions in tumor metastasis were analyzed by carbohydrate remodeling of a mouse Lewis lung cancer (subline P29) by introducing beta1,4GalNAc-T cDNA. Although P29 was originally a low-metastatic subline in the s.c. injection system, it showed high potential in lung metastasis when i.v.-injected via the tail vein. Two lines of GM(2)(+) transfectants showed markedly reduced metastatic potential to the lung compared to 2 control lines. However, cell proliferation rates and expression levels of various cell adhesion molecules, e.g., integrin family members, SLe(x) and CD44, were essentially unchanged after transfection of the cDNA. Then, cell adhesion to fibronectin-coated dishes was examined, showing that GM(2) (+) transfectants attached to the plates much more slowly than controls, suggesting functional modulation of integrins with newly expressed GM(2). Phosphorylation of the FAK located at downstream of integrin molecules was markedly reduced in GM(2)(+) transfectants, suggesting that GM(2) suppressed cell adhesion signals via fibronectin-integrin interaction. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12455030     DOI: 10.1002/ijc.10797

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Assessment of the molecular expression and structure of gangliosides in brain metastasis of lung adenocarcinoma by an advanced approach based on fully automated chip-nanoelectrospray mass spectrometry.

Authors:  Alina D Zamfir; Alina Serb; Željka Vukeli; Corina Flangea; Catalin Schiopu; Dragana Fabris; Svjetlana Kalanj-Bognar; Florina Capitan; Eugen Sisu
Journal:  J Am Soc Mass Spectrom       Date:  2011-10-15       Impact factor: 3.109

2.  Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.

Authors:  Kazunori Hamamura; Keiko Furukawa; Takanori Hayashi; Takeshi Hattori; Junji Nakano; Hideyuki Nakashima; Tetsuya Okuda; Hideki Mizutani; Hisashi Hattori; Minoru Ueda; Takeshi Urano; Kenneth O Lloyd; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

3.  Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

Authors:  Georgios T Stathopoulos; Zhiwen Zhu; M Brett Everhart; Ioannis Kalomenidis; William E Lawson; Semra Bilaceroglu; Todd E Peterson; Daphne Mitchell; Fiona E Yull; Richard W Light; Timothy S Blackwell
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-06       Impact factor: 6.914

4.  Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains.

Authors:  Yuki Ohkawa; Sayaka Miyazaki; Kazunori Hamamura; Mariko Kambe; Maiko Miyata; Orie Tajima; Yuhsuke Ohmi; Yoshio Yamauchi; Koichi Furukawa; Keiko Furukawa
Journal:  J Biol Chem       Date:  2010-06-25       Impact factor: 5.157

Review 5.  Signaling domains of cancer-associated glycolipids.

Authors:  Koichi Furukawa; Yuhsuke Ohmi; Kazunori Hamamura; Yuji Kondo; Yuki Ohkawa; Kei Kaneko; Noboru Hashimoto; Farhana Yesmin; Robiul H Bhuiyan; Orie Tajima; Keiko Furukawa
Journal:  Glycoconj J       Date:  2022-03-22       Impact factor: 2.916

6.  Differential roles of gangliosides in malignant properties of melanomas.

Authors:  Yuhsuke Ohmi; Mariko Kambe; Yuki Ohkawa; Kazunori Hamamura; Orie Tajima; Rika Takeuchi; Koichi Furukawa; Keiko Furukawa
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.